Stock Analysis·← Pickers

PBH

Prestige Consumer Healthcare Inc.

Prestige Consumer Healthcare Inc. (PBH) is currently in a downtrend, trading below both the 50-day and 200-day moving averages. RSI is at 50.0, with 0/3 trend checks passing.

Price
$48.36
2026-07-16
Trend score
0/3
Downtrend
RSI (14)
50.0
Neutral
Price above MA50Price above MA200MA50 above MA200
Change stock
Search another ticker to view its stock analysis page.
Chart View

PBH with MA50 and MA200

81.0472.1463.2454.3445.4407/3110/2401/2204/1707/15
PBH2025-07-312026-07-15
PriceMA50MA200
Technical Indicators

Key levels & signals

MA50
$48.45-0.18% vs price
MA200
$58.68-17.58% vs price
RSI (14)
50.0Neutral zone
MACD Signal
BullishMomentum above signal
Macro Support
Not identifiedNo repeated weekly support zone found
Support Quality
Volume data unavailable
Chart Summary
Trend summary for PBH

Prestige Consumer Healthcare Inc. (PBH) currently looks weaker on the chart and is not showing much trend strength. The latest available price is $48.36, and 0 of 3 core trend checks are currently passing. Price is trading below the 50-day moving average by 0.2% and below the 200-day moving average by 17.6%.

Momentum and stretch context

PBH currently has an RSI reading of 50.0, which sits in a neutral range. That usually means momentum is not especially stretched in either direction, so traders may need to rely more on chart structure than on oscillator extremes alone.

What traders may watch next

For traders reviewing PBH next, the main question is whether weakness is starting to stabilise or whether the chart still looks vulnerable to further downside. Some traders may watch for bounce attempts, but others will want to see stronger proof that the trend is improving before treating the stock as a cleaner setup.

Company profile

About Prestige Consumer Healthcare Inc.

Prestige Consumer Healthcare Inc., along with its various divisions, is involved in the creation, production, promotion, and distribution of non-prescription health and personal care items across both domestic (U.S.) and global markets. The company's business activities are structured into two principal areas: North American Over-the-Counter Healthcare and International Over-the-Counter Healthcare. Their extensive brand catalog features a diverse array of consumer health solutions, including popular choices for pain relief (such as BC/Goody's), infant care (Boudreaux's Butt Paste), sore throat remedies (Chloraseptic), vision care (Clear Eyes, TheraTears), wart treatment (Compound W), dental hygiene (DenTek), earwax removal (Debrox), and motion sickness prevention (Dramamine). The product line further extends to include digestive aids (Fleet, Gaviscon), cough suppressants (Luden's), feminine hygiene items (Monistat, Summer's Eve), treatments for lice and parasites (Nix), nasal washes (Fess), and rehydration therapies (Hydralyte). These offerings reach consumers through a wide range of retail channels, such as large discount retailers, pharmacies, supermarkets, dollar stores, convenience outlets, membership-based clubs, and digital commerce platforms. Founded in 1996 and based in Tarrytown, New York, the organization operated under the name Prestige Brands Holdings, Inc. until its rebranding to Prestige Consumer Healthcare Inc. in August 2018.

Sector
Healthcare
Industry
Medical - Distribution
CEO
Ronald Lombardi
Employees
890
Market cap
$2.29B
Beta
0.35
52-week range
$42.62 – $77.45
Dividend
No
Exchange
NYSE
Country
US
IPO date
10 Feb 2005
ISIN
US74112D1019
CUSIP
74112D101
Company profile data from Financial Modeling Prep. PBH listed on NYSE.
Learn More

Learn the indicators behind this page

Explore More

More stock opportunities

FAQ

Common questions about PBH

Is this page a buy or sell recommendation?

No. This page is designed to help you review chart structure, momentum and technical context more quickly, but it is not personal financial advice.

Why can a stock look bullish and overbought at the same time?

Strong trending stocks can still become stretched in the short term. That is why trend traders and dip buyers can read the same chart differently.

What should I do next after reading this page?

Open the full dashboard, review the chart in more detail, compare indicators, and decide whether the setup still makes sense within your own process.